AIIMS-Delhi has achieved a milestone in stroke care by conducting the country’s first dedicated clinical trial of a cutting-edge and advanced brain stent made for treating severe strokes.

The GRASSROOT trial, which evaluated the Supernova stent (Gravity Medical Technology), has found excellent safety and efficacy outcomes in the treatment of severe strokes, officials said.

The results were published in the ‘Journal of Neurointerventional Surgery’ (JNIS), part of the prestigious British Medical Journal group.

AIIMS-Delhi was the national coordinating centre and the lead enrolling site for the GRASSROOT trial – India’s first clinical trial of a new and advanced stroke treatment device, the Supernova stent, the officials said.

“This trial is a turning point for stroke treatment in India,”

See Full Page